Scientists say the results of the latest research examining the inflammation-fighting qualities of fluvoxamine, capping similar smaller studies, could lead to new treatment guidelines.
Published: October 28, 2021 at 12:30AM
from NYT Health https://ift.tt/3CrRRvh